Minimal residual disease (MRD) and risk-oriented therapy in adult acute lymphoblastic leukemia (ALL)

Bassan, R; Spinelli, O; Oldani, E; Intermesoli, T; Tosi, M; Giuseppe, R; Pogliani, Em; Angelucci, E; Fabris, P; Lambertenghi Deliliers, G; Polistena, P; Di Bona, E; Ciceri, Fabio; Leoni, F; Minotto, C; Mattei, D; Musso, M; Barbui, T; Rambaldi, A.